Dr. Reddy's Laboratories Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For DRREDDY, that strike is ₹1,180. Spot at ₹1,151 is 2.5% below max pain — possible upward gravitational pull into expiry.
Max Pain Level
The current max‑pain strike for DRREDDY is ₹1180. Max pain represents the strike at which option writers would incur the smallest aggregate loss, acting as a magnetic point that options prices often gravitate toward as expiry approaches.
Spot vs Max Pain Gap
The market is trading at ₹1151, roughly 2.46 % below the max‑pain level. This modest gap suggests the spot may be pulled upward toward the ₹1180 strike as the expiration date draws nearer, especially if underlying momentum supports a reversal.
Shift Signal
There is no shift in the max‑pain level from yesterday, indicating that option writers have not altered their positioning en masse. A stable max‑pain strike typically reflects a balanced view among writers, with neither side aggressively rebalancing their delta exposure.
Expiry Context
Max pain is derived from the sum of open‑interest across all call and put strikes; the strike with the lowest total loss for writers becomes the “pain” point. During the final week before expiry, market participants often see price movement that nudges the underlying toward this strike, though the effect is a tendency, not a certainty. Historical patterns show that stocks can still close well away from the max‑pain level if broader market forces dominate.
Data Note
With 25 days remaining to the September 29 expiry, the spot sits ₹29 below the current max‑pain strike of ₹1180.
Data as of 2026-09-04